Ronald I. Simon - 09 Sep 2026 Form 4 Insider Report for Ellington Financial Inc. (EFC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Sep 2026, 16:10:33 UTC
Prior SEC filing
02 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alaael-Deen Shilleh, as attorney-in-fact for Ronald I. Simon

Key filing fact

Ronald I. Simon filed Form 4 for Ellington Financial Inc. (EFC) on 10 Sep 2026.

Key facts

  • This page summarizes Ronald I. Simon's Form 4 filing for Ellington Financial Inc. (EFC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Sep 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 02 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001060435 Primary reporting owner

SIMON RONALD I

Relationship
Director
Address
53 FOREST AVE, OLD GREENWICH
Signature
/s/ Alaael-Deen Shilleh, as attorney-in-fact for Ronald I. Simon
Signature date
10 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EFC transaction

Common Stock

Award

Transaction value
Shares
+10,181
Change %
+13%
Price
$0.000000*
Shares after
90,181
Date
09 Sep 2026
Ownership
By Trust
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The 10,181 shares of common stock, $0.001 par value per share (the "Common Shares") remain forfeitable, subject to the reporting person's continued service as a member of the board of directors of Ellington Financial Inc. (the "Company"), until September 8, 2027. The Common Shares were issued pursuant to, and are subject to the terms and conditions of the Company's 2026 Equity Incentive Plan.

Footnote F2

The 10.181 Common Shares issued to Dr. Simon on September 9, 2026 are held at the transfer agent of the Company. As of the time of filing, other than 5,544 Common Shares held in an investment retirement account, all of the remaining Common Shares held by Dr. Simon were held in the Simon Family Trust (the "Trust"). Dr. Simon is a trustee of the Trust. Dr. Simon and his wife are the beneficiaries of the Trust. Dr. Simon disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .